Please login to the form below
Unpacking rare diseases in the first edition of Delta magazine
Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization.
Welcome to Delta – the new Fishawack Health magazine.
We’ve chosen to focus our first edition of the magazine on a topic close to our hearts, rare diseases.
Rare diseases represent an incredibly high unmet need, not only due to the lack of therapies and the practical difficulties in diagnosis, but also in patients’ desire for better knowledge, communication, and more meaningful relationships with their healthcare professionals.
As our rare disease specialist agency Dudnyk says: “We are seeing a growing separation between healthcare professionals and patients. The impact of this great divide in understanding is negatively affecting the treatment experience—for both sides—as well as severely limiting the trajectory of specialty healthcare brands.”
The dynamic between patients and healthcare professionals, combined with the challenges of patient identification and data generation in tiny patient populations (made even more challenging in a global pandemic), means rare disease drug development and launch requires a unique business model.
In this edition of Delta, our consultants, creatives and medical communications experts explore the challenges and opportunities for life science companies operating in rare disease, including:
- Navigating real-world evidence and why it could be a gamechanger in rare disease
- A patient’s account of living with a rare disease in the COVID-19 pandemic
- How to make an impact in small patient populations
- The lessons Dan Zaksas, PhD, Senior Vice President, Director of Scientific and Medical Affairs at Dudnyk, has learned during a decade working in rare diseases
- Why you need to build relationships with KOLs and patients much earlier than you think
- The lasting implications of COVID-19 on the life science industry.
Company Details
Fishawack Health
Address:
No. 3 Booths Park
Booths Hall
Chelford Road
Knutsford
Cheshire
WA16 8GS
United Kingdom
Latest content on this profile
- How to innovate and influence people in times of misinformation
- The pandemic has shown that public trust in promising new medical technologies is far from a given. Senior Writer Tom Vandyck at StoneArch, a member of Fishawack delves into the right approach to help companies with breakthrough innovations in their pipeline build consumer confidence.
Fishawack Health
- Fishawack Health welcomes expert-led dermatology initiative FIDE to its group
- Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology
Fishawack Health
- Rethinking immunodermatology: Patient and market insights from leading KOLs and life science leaders
- In our new publication, we speak to key opinion leaders and industry experts to uncover novel strategies for commercializing immunodermatology therapies in a crowded market landscape.
Fishawack Health
- How we’re empowering our teams to fight healthcare inequality
- Welcoming Sheena Amin-Liebman as our new Diversity and Inclusion Director. Sheena will play a vital role in creating an inspiring environment that empowers staff to better guide its clients in their work to improve health outcomes for the patients they serve.
Fishawack Health
- Accelerating HTA and payer submissions: how digital connectivity is driving faster patient access
- Sotiria Papanicolaou, Chief Consulting Officer at PRMA Consulting, a member of Fishawack Health, explains how the combination of digital innovation and expert insight are removing roadblocks and speeding up the generation of health technology assessments (HTA) and payer submissions for pharma.
Fishawack Health
- Future focus: 3 tools for launching fast in the face of uncertainty
- Dan Twibell, Head of Commercial Strategy, Consulting at Fishawack Health, reveals 3 fundamental tools for lean biotechs approaching a rapid launch. He gives his advice on how to manage resources effectively and ensure the strategy remains agile in a changing market landscape.
Fishawack Health
